Detalhe da pesquisa
1.
Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination: Results of a randomized trial.
Am J Transplant;
19(3): 811-822, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30125462
2.
Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study.
Pediatr Transplant;
21(7)2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28714558
3.
Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials.
Transplantation;
105(7): 1564-1575, 2021 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33741847
4.
Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection.
Ann Transplant;
20: 25-35, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25588713
5.
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study.
Transplantation;
99(7): 1455-62, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26151607
6.
Methodological challenges in monitoring new treatments for rare diseases: lessons from the cryopyrin-associated periodic syndrome registry.
Orphanet J Rare Dis;
8: 139, 2013 Sep 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24016338